CClinicalTrials.gg
CompletedNCT02518386EpiToxUpdated Apr 17, 2019

Epidemiology of Acute Self-poisoning in Emergency Services in France

An observational study in Suicide Attempts, sponsored by University Hospital, Grenoble. Completed. Per ClinicalTrials.gov, last updated 2019-04-17.

Sponsored by University Hospital, Grenoble · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
700
Sex
All
01

Study summary

Acute self poisoning is a leading cause of suicide attempts and leads to frequent emergency department visits. However, the exact epidemiology of acute self poisoning is not known. The description of the clinical pathway and the characteristics of patients with acute self poisoning could lead to an improvement in emergency care.

The Investigators will conduct a 48h observational study in emergency services in France. Investigators primary objective is to gathered epidemiological clinical and treatment data during emergency dispatch, prehospital care and inhospital emergency care.

Read the detailed description

Acute self poisoned patients will be prospectively and anonymously recruited by emergency physicians in charge during two days. Acute self poisoning is define as follow: intentional medicine intake in the 24h hours before emergency department admission.

Epidemiological, clinical, toxicological and treatment data will be gathered. Outcome of patient will be prospectively assessed at 30days.

All data will be transmitted to the principal investigators. Then, 20% of the data will be monitored by an independent committee.

Exhaustivity will be retrospectively assessed by the number of inclusions in 10 emergency centers divided by the total number of possible inclusions in these centers.

Finally, an independent statistician will be in charge of the analysis.

02

Conditions studied

  • Suicide Attempts

Keywords

  • emergency department
  • epidemiology
  • prehospital care
  • dispatch
  • acute self poisoning
03

In context

Emergencies

1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.

This study's enrollment of 700 is above the median of 353 across 714 observational studies indexed under Emergencies.

Browse Emergencies studies →

Lead sponsor

University Hospital, Grenoble is the lead sponsor of 815 studies on the registry; 205 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients dispatched of admitted for acute self poisoning in emergency medical services and/or emergency departments

Inclusion criteria

  • acute self poisoning defined as the intentional intake (oral, nasal, injection etc.) of medicines during the 24h before first medical contact

Exclusion criteria

Exclusion Criteria:

  • cardiac arrest at first medical contact (dispatch or physician)
  • acute self poisoning without any medication intake
  • non intentional poisoning
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
700 participants (actual)
Target follow-up
1 Month
Patient registry
Yes

Interventions

  • OtherNo intervention

    No intervention is planned

06

What researchers measure

Primary outcomes

  1. Percentage of each drug class

    Time frame: 48h

Secondary outcomes

  1. odds ratio of drug classes according to sexe and age

    Time frame: 48h

  2. number of participants with poisoning incident

    Time frame: 48h

  3. prehospital and inhospital mortality

    Time frame: 30 days

  4. percentage of each antidotal treatment

    Time frame: 48h

  5. mobile intensive care unit (percentage) dispatch

    Time frame: 30 days

  6. Age according to drug classes ingestion

    Median age compared according drug classes ingestion

    Time frame: 48h

  7. Gender according to drug classes ingestion

    Pourcentage of gender compared according drug classes ingestion

    Time frame: 48h

  8. Time (median) of admission according to drug classes ingestion

    Time frame: 48h

  9. Time (median) of admission according unit of admission

    Time frame: 48h

  10. Mortality according to drug class ingestion

    Time frame: 30 days

  11. ICU admission according to drug class ingestion

    Time frame: 30 days

  12. icu admission (percentage)

    Time frame: 48h

  13. percentage of errors according to the Grenoble clinical decision rule

    Time frame: 30 days

  14. multivariate analysis to describe factors associated with ICU admission

    Time frame: 30 days

  15. multivariate analysis to describe factors associated with mobile intensive care unit dispatch

    Time frame: 30 days

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 17, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02518386
Lead sponsor
University Hospital, Grenoble
Collaborators
French Society of Emergency Medicine
Responsible party
Sponsor
First posted
Aug 7, 2015
Start date
Mar 2015
Primary completion
Apr 2015
Completion
Jun 2016
Last update
Apr 17, 2019

Study contacts

Maxime Maignan, MD MSc
principal investigator · Emergency department, CHU Grenoble

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion